<PAGE> 1
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): July 11, 1997
MEDICAL TECHNOLOGY SYSTEMS, INC.
- --------------------------------------------------------------------------------
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
Delaware 0-16594 59-2740462
-------- ------- ----------
(State or other jurisdiction (Commission File Number) (IRS Employer
of incorporation) Identification No.)
</TABLE>
12920 Automobile Boulevard, Clearwater, Florida 34622
- --------------------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (813) 576-6311
N/A
- --------------------------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE> 2
ITEM 5. OTHER EVENTS
Medical Technology Systems, Inc. (the "Company") has outstanding 1,320,000
warrants (the "Warrants"), each of which is exercisable to purchase one share
of the Company's common stock for $7.00. The Warrants are callable by the
Company, upon 30 days' written notice, for $0.05 per Warrant. The Warrants
were scheduled to expire on July 17, 1997. On July 11, 1997, the Company
extended the expiration date of the Warrants from July 17, 1997 to July 17,
1998. All other conditions of the Warrants remain the same.
ITEM 7. FINANCIAL STATEMENTS AND EXHIBITS
(c) Exhibits.
4.1 Form of Second Amendment to Warrant Agreement.
Page 2 of 4 Pages
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this Report to be signed on its behalf by the
undersigned hereunto duly authorized.
MEDICAL TECHNOLOGY SYSTEMS, INC.
(Registrant)
By:/s/ Michael P. Conroy
------------------------------------------
Michael P. Conroy, Chief Financial Officer
Date: July 11, 1997
Page 3 of 4 Pages
<PAGE> 4
EXHIBIT INDEX
MEDICAL TECHNOLOGY SYSTEMS, INC.
Current Report on Form 8-K
Dated July 11, 1997
<TABLE>
<CAPTION>
EXHIBIT NO. DESCRIPTION
<S> <C>
4.1 Form of Second Amendment to Warrant Agreement.
</TABLE>
Page 4 of 4 Pages
<PAGE> 1
Exhibit 4.1
SECOND AMENDMENT TO WARRANT AGREEMENT
This Second Amendment to Warrant Agreement (the "Second Amendment") is
effective as of this ___ day of July, 1997, by and between Medical Technology
Systems, Inc., a Delaware corporation (the "Company"), and Continental Stock
Transfer & Trust Company, as Warrant Agent (the "Warrant Agent").
BACKGROUND
The Company originally entered into a Warrant Agreement with the
Warrant Agent in connection with a public offering of the Company's securities
pursuant to a prospectus dated July 17, 1991. On July 2, 1996, the parties
executed an Amendment to Warrant Agreement (the "Amendment") that extended to
July 17, 1997 from July 17, 1996 the expiration date of the warrants to
purchase shares of the Company's common stock (the "Warrants"). The parties
desire to amend the Warrant Agreement and the Amendment for purposes of further
extending the expiration date of the Warrants.
Therefore, for good and valuable consideration, the receipt and
adequacy of which are hereby acknowledged, the parties agree as follows:
TERMS
1. Expiration Date of Warrants. The Warrant Expiration Date is
hereby extended to July 17, 1998 from July 17, 1997.
2. No Other Effect. Except as specifically set forth above, this
instrument shall not affect the rights of the parties under the Warrant
Agreement or the Amendment.
3. Counterparts, Amendment, and Construction. This instrument:
(a) may be executed in two or more counterparts, each of which shall be deemed
an original, and all of which together shall constitute one instrument; (b)
cannot be amended, modified, or supplemented in any respect except by a
subsequent written agreement entered into by all the parties to this Second
Amendment; and (c) shall be construed and enforced in accordance with the laws
of Florida.
<PAGE> 2
IN WITNESS WHEREOF, the parties have executed this Second Amendment
effective as of the date first written above.
MEDICAL TECHNOLOGY SYSTEMS, INC.
By:
---------------------------------------
Michael P. Conroy, Vice President
and Chief Financial Officer
CONTINENTAL STOCK TRANSFER &
TRUST COMPANY
By:
---------------------------------------
Authorized Officer
2
